Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE

v3.24.1
EARNINGS PER SHARE
9 Months Ended
Jan. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE

NOTE 11 – EARNINGS PER SHARE

 

Basic earnings (loss) per share is computed by dividing earnings (loss) available to common stockholders by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares and potentially dilutive shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would be outstanding if the potentially dilutive securities had been issued. Potential shares of common stock outstanding principally include preferred stock, stock options and warrants. During the three and nine months ended January 31, 2024 and 2023, the Company incurred losses attributable to common stockholders. Accordingly, the effect of any common stock equivalent would be anti-dilutive during those periods and are not included in the calculation of diluted weighted average number of shares outstanding.

 

The table below sets forth the basic loss per share calculations:

           
    Three Months Ended January 31,  
    2024     2023  
Net loss attributable to common stockholders   $ (5,620,113 )   $ (764,136 )
Basic and diluted weighted average number of shares outstanding     8,606,957       18,995,442  
Basic and diluted loss per share   $ (0.65 )   $ (0.04 )

 

             
    Nine Months Ended January 31,  
    2024     2023  
Net loss attributable to common stockholders   $ (14,696,861 )   $ (4,189,655 )
Basic and diluted weighted average number of shares outstanding     9,991,326       20,051,617  
Basic and diluted loss per share   $ (1.47 )   $ (0.21 )

 

The table below sets forth these potentially dilutive securities:

     
    Nine Months Ended January 31,  
    2024     2023  
Excluded options     779,794       281,936  
Excluded warrants     18,570,847       9,890,847  
Series B convertible preferred stock     5,929,053        
Total preferred stock, options and warrants     25,279,694       10,172,783